Why the study?
Are elevated creatine kinase and fibrillation potentials associated with delayed weakness in patients with late sequelae of polio?
Are elevated creatine kinase and fibrillation potentials associated with delayed weakness in patients with late sequelae of polio?
Elevated CK and increased fibrillation potentials in polio patients with delayed weakness suggest that late denervation, rather than muscle overuse, may play a role in the development of new weakness.
May flag late denervation in post-polio weakness; hypothesis-generating and should not yet change practice.
The incidence of an elevated creatine kinase (CK) in a group of polio patients with delayed weakness (15/29) did not differ from polio patients without delayed weakness (9/31) or others with amyotrophic lateral sclerosis (ALS; 10/21). Mean CK in polio patients without delayed weakness (151 IU/L) was lower than the CK in those with delayed weakness (270 IU/L) or ALS (224 IU/L) (P less than 0.05). An elevated CK in polio patients with delayed weakness did not correlate with new or residual weakness. These findings suggest that muscle overuse is either not important or inadequately measured by CK. Widely distributed fibrillations were associated with an elevated CK for all polio patients combined (P less than 0.01). Fibrillations occurred in more muscles of polio patients with delayed weakness (P less than 0.01) and implies that late denervation may play a role in the development of new weakness in some polio patients.
No takes yet. Share an insight, caveat, or question.
Kevin R. Nelson (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: